Analyze Diet
Equine veterinary journal1994; 26(3); 246-248; doi: 10.1111/j.2042-3306.1994.tb04379.x

Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia.

Abstract: No abstract available
Publication Date: 1994-05-01 PubMed ID: 8542848DOI: 10.1111/j.2042-3306.1994.tb04379.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Cite This Article

APA
Kenney DG, Robbins SC, Prescott JF, Kaushik A, Baird JD. (1994). Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. Equine Vet J, 26(3), 246-248. https://doi.org/10.1111/j.2042-3306.1994.tb04379.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 26
Issue: 3
Pages: 246-248

Researcher Affiliations

Kenney, D G
  • Department of Clinical Studies, University of Guelph, Ontario, Canada.
Robbins, S C
    Prescott, J F
      Kaushik, A
        Baird, J D

          MeSH Terms

          • Actinomycetales Infections / complications
          • Actinomycetales Infections / drug therapy
          • Actinomycetales Infections / veterinary
          • Animals
          • Anti-Bacterial Agents / pharmacology
          • Anti-Bacterial Agents / therapeutic use
          • Antibiotics, Antitubercular / pharmacology
          • Antibiotics, Antitubercular / therapeutic use
          • Arthritis, Reactive / diagnosis
          • Arthritis, Reactive / etiology
          • Arthritis, Reactive / veterinary
          • Drug Resistance, Microbial
          • Drug Therapy, Combination
          • Erythromycin / pharmacology
          • Erythromycin / therapeutic use
          • Female
          • Horse Diseases / diagnosis
          • Horse Diseases / drug therapy
          • Horse Diseases / etiology
          • Horses
          • Lung / microbiology
          • Lung / pathology
          • Pneumonia, Bacterial / complications
          • Pneumonia, Bacterial / drug therapy
          • Pneumonia, Bacterial / veterinary
          • Rheumatoid Factor / analysis
          • Rhodococcus equi / drug effects
          • Rhodococcus equi / isolation & purification
          • Rifampin / pharmacology
          • Rifampin / therapeutic use
          • Synovial Fluid / chemistry

          Citations

          This article has been cited 9 times.
          1. Huber L, Giguère S, Slovis NM, Carter CN, Barr BS, Cohen ND, Elam J, Erol E, Locke SJ, Phillips ED, Smith JL. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017. Antimicrob Agents Chemother 2019 Jan;63(1).
            doi: 10.1128/AAC.01714-18pubmed: 30373803google scholar: lookup
          2. Huber L, Giguère S, Berghaus LJ, Hanafi A, Vitosh-Sillman S, Czerwinski SL. Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi. PLoS One 2018;13(2):e0192655.
            doi: 10.1371/journal.pone.0192655pubmed: 29415076google scholar: lookup
          3. Schlusselhuber M, Torelli R, Martini C, Leippe M, Cattoir V, Leclercq R, Laugier C, Grötzinger J, Sanguinetti M, Cauchard J. The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice. Antimicrob Agents Chemother 2013 Oct;57(10):4615-21.
            doi: 10.1128/AAC.02044-12pubmed: 23817377google scholar: lookup
          4. Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J. In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment. Antimicrob Agents Chemother 2012 Apr;56(4):1749-55.
            doi: 10.1128/AAC.05797-11pubmed: 22232283google scholar: lookup
          5. Buckley T, McManamon E, Stanbridge S. Resistance studies of erythromycin and rifampin for Rhodococcus equi over a 10-year period. Ir Vet J 2007 Dec 1;60(12):728-31.
            doi: 10.1186/2046-0481-60-12-728pubmed: 21851690google scholar: lookup
          6. Fines M, Pronost S, Maillard K, Taouji S, Leclercq R. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J Clin Microbiol 2001 Aug;39(8):2784-7.
          7. Takai S, Takeda K, Nakano Y, Karasawa T, Furugoori J, Sasaki Y, Tsubaki S, Higuchi T, Anzai T, Wada R, Kamada M. Emergence of rifampin-resistant Rhodococcus equi in an infected foal. J Clin Microbiol 1997 Jul;35(7):1904-8.
          8. Vandersnickt J, Van PJ, Vandamme S, Kenyon C, Florence E, Van Ierssel S, Vlieghe E, Theunissen C. Rhodococcus equi, an Unusual Human Pathogen That Causes Cavitating Pneumonia in Patients With AIDS. Case Rep Infect Dis 2024;2024:5570186.
            doi: 10.1155/2024/5570186pubmed: 39545099google scholar: lookup
          9. Giguère S, Berghaus LJ, Willingham-Lane JM. Antimicrobial Resistance in Rhodococcus equi. Microbiol Spectr 2017 Oct;5(5).